HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer : a meta-analysis of individual patient data

HER2/TOP2A Meta-analysis Study Group, HER2 / TOP2A Meta-analysis Study Group

    Research output: Contribution to journalArticleScientificpeer-review

    150 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1134-1142
    JournalLANCET ONCOLOGY
    Volume12
    Issue number12
    DOIs
    Publication statusPublished - 2011
    Publication typeA1 Journal article-refereed

    Cite this